# Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes

> **NCT01496430** · PHASE3 · TERMINATED · sponsor: **Takeda** · enrollment: 105 (actual)

## Conditions studied

- Hypertension
- Diabetes

## Interventions

- **DRUG:** Placebo
- **DRUG:** Azilsartan medoxomil
- **DRUG:** Azilsartan medoxomil

## Key facts

- **NCT ID:** NCT01496430
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 105 (ACTUAL)
- **Why stopped:** Business Decision; No Safety Or Efficacy Concerns. (See below)
- **Last updated:** 2015-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01496430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01496430, "Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01496430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*